Top medical experts to grace Sidra conference

SidraMedicine, a member of the Qatar Foundation for Education, Science andCommunity Development will bring together world-leading experts andpractitioners from 10 countries for a symposium to accelerate advancedand experimental therapies.The two day ‘Advanced TherapiesSymposium’ starting from this Saturday at Four Seasons Doha, aims toshare knowledge and research and spur innovation in advanced treatmentsranging from cellular, gene therapy, molecular-targeted therapies andimmunotherapy.The conference will help ongoing research and drivescientific knowledge in the area of translational research and earlyclinical applications. It will shed light into the development phases,clinical trials, and regulatory aspects of these therapies, particularlyin the field of Oncology, Haematology, Immunology, Inflammatory andAutoimmune disorders, to engender better and more personalised treatmentoptions, and bring important health benefits.Those interested inattending can register  athttp://events.sidra.org/event/advanced-therapies-in-healthcare/  and a limited number of spaces are available for on-site registration on bothdays.The conference will feature leading figures and experts fromthe Middle East, Europe and the US. Key international speakers at theevent include Soldano Ferrone, faculty member of the Department ofSurgery at Massachusetts General Hospital, Harvard Medical School,Adrian Thrasher, professor of paediatric immunology at UCL Great OrmondStreet Institute of Child Health, and Michele Maio, director of theCentre for Immuno-Oncology at University Hospital of Siena, amongst manyothers. Providing a rich mixture of workshop sessions and keynotelectures, the conference is open to physicians, nurses, pharmacists,allied health providers, medical students and other practitioners whocare for patients with oncological, haematological, immunology,inflammatory and autoimmune disorders. Attendees at the symposium cangain 14.75 Continuing Medical Education (CME) points since it is anAccredited Group Learning Activity (Category 1).Dr Chiara Cugno,director, Clinic Research at Sidra Medicine said, “We are committed tocreating effective platforms for healthcare professionals tocollaborate, share best practices and methodologies and to developingprogrammes that advance personalised medicine in Qatar and beyond. Thisconference is a critical part of our long-term goal to boost theintroduction of advanced treatments, especially in cell and gene therapyin Qatar. It goes a long way towards supporting our ambition tointroduce ground-breaking technologies and techniques that willsignificantly improve the lives of children, young people and women inthe country.”